Manufacturer of Controlled Substances; Notice of Application, 18570 [E8-7039]
Download as PDF
18570
Federal Register / Vol. 73, No. 66 / Friday, April 4, 2008 / Notices
Maps appearing here in the comment
are illegible upon reprinting. The maps
are available at the Department of
Justice Antitrust Division, 325 Seventh
Street, NW., Room 215, Washington, DC
20530, (202) 514–2481, and at the Office
of the Clerk of the United States District
Court for the District of Columbia, 333
Constitution Avenue, NW., Washington,
DC 20001.
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Fentanyl (9801) ............................
I
II
II
II
II
II
II
II
II
II
II
II
controlled substances listed in
schedules I and II:
Drug
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Schedule
I
II
II
II
II
II
II
II
II
II
II
II
II
II
North Lamar County Citizens
Association
P.O. Box 516, Milner, Georgia 30257.
‘‘Quality Growth, Quality Life’’
January 14, 2008.
Maribeth Petrizzi, Chief, Litigation II
Section, Antitrust Division, U.S.
Department of Justice, 1401 H Street
NW., Suite 3000, Washington, DC
20530.
Supplement To Comment
Re: USA DOJ v. Vulcan Materials
Company and Florida Rock Industries,
Inc., Case: I:07–cv–02044.
Dear Ms. Petrizzi,
After sending our comment I realized
there was no contact information
included. Accordingly, below is my
contact information. Also attached are
photos showing that FRI has already
begun working at the Lamar County
Quarry.
If you have any questions, please feel
free to call me.
Sincerely,
Jonathan P. Sexton
President, North Lamar County Citizens
Association
Contact: Jonathan P. Sexton.
Phone: 770–474–9335.
Fax: 770–474–7113.
E-mail: jonsclerk@yahoo.com.
Photographs appearing here in the
comment are illegible upon reprinting.
The photographs are available at the
Department of Justice Antitrust
Division, 325 Seventh Street, NW.,
Room 215, Washington, DC 20530, (202)
514–2481, and at the Office of the Clerk
of the United States District Court for
the District of Columbia, 333
Constitution Avenue, NW., Washington,
DC 20001.
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 3, 2008.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 3, 2008.
Dated: March 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–7037 Filed 4–3–08; 8:45 am]
Dated: March 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–7039 Filed 4–3–08; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
[FR Doc. E8–6875 Filed 4–3–08; 8:45 am]
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Executive Office for Immigration
Review
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Application
[OMB Number 1125–0003]
Drug Enforcement Administration
Pursuant to 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 10, 2008,
Siegfried (USA), Inc., Industrial Park
Road, Pennsville, New Jersey 08070,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
ebenthall on PRODPC61 with NOTICES
BILLING CODE 4410–11–C
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 5, 2008,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
VerDate Aug<31>2005
15:24 Apr 03, 2008
Jkt 214001
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
II
II
60-day notice of information
collection under review: fee waiver
request.
ACTION:
The Department of Justice (DOJ),
Executive Office for Immigration
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 73, Number 66 (Friday, April 4, 2008)]
[Notices]
[Page 18570]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-7039]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 10, 2008, Siegfried
(USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than June 3, 2008.
Dated: March 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-7039 Filed 4-3-08; 8:45 am]
BILLING CODE 4410-09-P